Professur für Molekulare Mechanismen der Organfibrose

Reallocation / Closing: 30.09.2022


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Molecular and epigenetic consequences of pre- and postnatal trauma in a mouse model (2017) Frey S, Steigleder R, Distler J, Kratz O, Moll G, Golub Y Conference contribution PREDICTION OF PROGRESSIVE SKIN THICKENING IN EARLY DIFFUSE SYSTEMIC SCLEROSIS USING THREE-MONTHLY SKIN SCORES FROM THE EUROPEAN SCLERODERMA OBSERVATIONAL STUDY (ESOS) (2017) Herrick A, Peytrignet S, Pan X, Hesselstrand R, Mouthon L, Brown E, Czirjak L, et al. Conference contribution LONG NONCODING RNA H19X AS A NEW THERAPEUTIC TARGET FOR FIBROSIS (2017) Pachera E, Wunderlin A, Assassi S, Salazar G, Frank-Bertoncelj M, Dobrota R, Brock M, et al. Conference contribution MICRORNA-125B AS A POTENTIAL FIBROTIC AND APOPTOTIC REGULATOR IN SYSTEMIC SCLEROSIS (2017) Kozlova A, Pachera E, Renoux F, Rudnik M, Maurer B, Juengel A, Distler J, et al. Conference contribution FRA2 OVEREXPRESSION LEADS TO SYSTEMIC AUTOIMMUNITY BY DECREASING IL-2 RESPONSIVENESS AND THYMIC TREG DEVELOPMENT (2017) Renoux F, Stellato M, Impellizzieri D, Vogetseder A, Huang R, Subramaniam A, Dees C, et al. Conference contribution Increased Plasma Levels of Hsp90 Are Associated with More Severe Organ Involvement in Patients with Systemic Sclerosis (2017) Storkanova H, Oreska S, Spiritovic M, Pavelka K, Vencovsky J, Distler J, Senolt L, et al. Conference contribution Fra-2 Overexpression Leads to Systemic Autoimmunity By Affecting IL2 Dependent Treg Homeostasis (2017) Renoux F, Stellato M, Impellizzieri D, Vogetseder A, Blyszczuk P, Huang R, Subramaniam A, et al. Conference contribution EPIGENETIC REGULATION OF FRA2 BY JMJD3 REGULATES FIBROBLAST ACTIVATION IN SYSTEMIC SCLEROSIS (2017) Bergmann C, Brandt A, Dees C, Wohlfahrt T, Zhang Y, Chen CW, Mallano T, et al. Conference contribution IMATINIB-LOADED TARGETED GOLD NANOPARTICLES AMELIORATE EXPERIMENTAL LUNG FIBROSIS INDUCED BY BLEOMYCIN (2017) Codullo V, Breda S, Meloni F, Cova E, Inghilleri S, Colombo M, Prosperi D, et al. Conference contribution EVALUATION OF FREQUENCY AND TYPE OF PHYSICAL THERAPY IN MORE THAN 3400 PATIENTS WITH SYSTEMIC SCLEROSIS (2017) Belz D, Moinzadeh P, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution